Filing Manager
HARBOURVEST PARTNERS LLC
Reporting Manager
HarbourVest Partners L.P.
Symbol
CAMP
Shares outstanding
20,189,651 shares
Disclosed Ownership
1,271,948 shares
Ownership
6.3%
Form type
SCHEDULE 13G
Filing time
14 May 2025, 13:45:31 UTC
Date of event
31 Dec 2024
Next filing
01 Oct 2025

Quoteable Key Fact

"HARBOURVEST PARTNERS LLC disclosed 6.3% ownership in CAMP4 Therapeutics Corporation Common Stock, par value $0.0001 per share (CAMP) on 31 Dec 2024."

Quick Takeaways

  • HARBOURVEST PARTNERS LLC filed SCHEDULE 13G for CAMP4 Therapeutics Corporation Common Stock, par value $0.0001 per share (CAMP).
  • Disclosed ownership: 6.3%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 May 2025, 13:45.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
HarbourVest Partners L.P. 6.3% 1,271,948 0 1,271,948 By: HarbourVest Partners, LLC, its General Partner; /s/ Adam Freedman Adam Freedman; Chief Compliance Officer
HarbourVest Partners, LLC 6.3% 1,271,948 0 1,271,948 /s/ Adam Freedman Adam Freedman; Chief Compliance Officer
SMRS-TOPE LLC 6.3% 1,271,948 1,271,948 0 By: HVST-TOPE LLC, its Managing Member; HarbourVest Partners L.P., its Manager; HarbourVest Partners, LLC, its General Partner; /s/ Adam Freedman Adam Freedman; Chief Compliance Officer
HVST-TOPE LLC 6.3% 1,271,948 0 1,271,948 By: HarbourVest Partners L.P., its Manager; HarbourVest Partners, LLC, its General Partner; /s/ Adam Freedman Adam Freedman; Chief Compliance Officer